Introduction and Objective: People living with type 1 diabetes (pwT1D) face barriers to physical activity (PA), such as fear of hypoglycemia, which may evolve over time. This longitudinal study aimed to evaluate changes in barriers to PA and to identify clinical and psychological factors influencing these changes.Methods: Data were obtained from adults pwT1D (≥18 years) […]
Read MoreAuthor: sugaradmin
Can the Viral Drink Actually Relieve Stress?
Share on PinterestTikTok users say the “cortisol cocktail” can help lower stress, but experts are skeptical about the benefits. Flashpop/Getty Images Proponents of the viral “cortisol cocktail” claim the drink can reduce stress and improve sleep, but there’s little evidence to support this claim. Its main ingredient, magnesium, may help support stress relief, but the […]
Read More1528-P: Sperm DNA Methylation Is Altered in Men with Type 1 Diabetes
Introduction and Objective: Type 1 diabetes (T1D) can impact reproductive health in males. Given the potential impact of environmental stimuli, including hyperglycemia, on epigenetic marks, we assessed DNA methylation (DNAm) in sperm from men with T1D.Methods: We recruited 29 weight and age-matched men, 19 with T1D and 10 normoglycemic controls (CON). Samples were collected at […]
Read More1149-P: Expanding Access to Continuous Glucose Monitoring in Medicare Patients through Quality Improvement
Introduction and Objective: In 2023, Medicare expanded coverage for continuous glucose monitoring (CGM) to include all patients with diabetes using insulin, but this update has been slow to disseminate to providers. This quality improvement project aimed to improve access to CGM for Medicare patients with type 2 diabetes on insulin at our subspecialty diabetes clinic.Methods: […]
Read More1387-P: Trends and Disparities in Mortality from Comorbid NIDDM and Stroke (1999–2022)—A Retrospective Analysis
Introduction and Objective: Comorbid non-insulin dependent diabetes mellitus (NIDDM) and stroke significantly contribute to mortality among older adults. This study examines age-adjusted mortality rates (AAMRs) and disparities by demographics, region, and age groups to identify trends throughout the period.Methods: Mortality data from CDC records for 55-85+ years were analyzed. AAMRs per 100,000 and annual percentage […]
Read More1148-P: Factors Responsible for Delay in Seeking Medical Help by Patients with Diabetic Foot Ulcers
Introduction and Objective: The increasing prevalence of Diabetes in India has led to a surge in Diabetic complications, including foot ulcers. This study investigates factors contributing to delayed seeking of medical help. This study also determines the prevalence of delayed presentation among patients with diabetic foot ulcers, highlighting patient-related and healthcare system-related factors essential for […]
Read More1992-LB: MYO4, a First-in-Class Antiobesogenic and Muscle Preserving Small Molecule Metabolic Modulator
Introduction and Objective: There is increasing concern with the amount muscle loss across GLP-1 receptor agonist (GLP1-RA) weight loss drugs (STEP1, SUSTAIN8, SURMOUNT-1, AWARD-11 trials etc). As low muscle mass predicts poor health outcomes and mitochondrial dysfunction is a critical obesogenic and atrophic driver, we developed novel mitochondria-targeted small molecules as muscle-preserving weight loss strategies […]
Read More1147-P: Equitable Access to Type 1 Diabetes Technology across a Health System
Introduction and Objective: Inequity in access to diabetes technology such as continuous glucose monitors (CGM) and automated insulin delivery systems (AID) leads to lower adoption in minority and low-income groups. In our urban academic health system, some sites integrate all payors while others have separate clinics for private versus public insurance. We aim to compare […]
Read MoreDiabetes Core Update : Special Edition – Obstructive Sleep Apnea (OSA) Part 2
In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss diagnosis of OSA. In Part 1 we discussed and overview of OSA, Part 3 will discuss treatment options, and Part 4 will look at cases. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil […]
Read More130-OR: Real-World Glycemic Outcomes in Adults with Type 2 Diabetes (T2D) Using the Omnipod 5 Automated Insulin Delivery (AID) System
Introduction and Objective: A recent trial of the Omnipod® 5 AID System showed improvement in glycemic outcomes following AID initiation in a cohort of adults with insulin-treated T2D. However, limited real-world data exist on AID use and bolus behaviors in this population. This analysis evaluated real-world outcomes with Omnipod 5 use in the management of […]
Read More